Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: January 27, 2023

Orbion Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for ORBION PHARMS, and what generic and branded alternatives to ORBION PHARMS drugs are available?

ORBION PHARMS has twenty-nine approved drugs.

Summary for Orbion Pharms

US Patents:	0
Tradenames:	27
Ingredients:	26
NDAs:	29

Drugs and US Patents for Orbion Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Orbion Pharms	ARIPIPRAZOLE	aripiprazole	TABLET;ORAL	202683-001	May 23, 2017	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Orbion Pharms	OLANZAPINE	olanzapine	TABLET;ORAL	202287-002	Apr 23, 2012	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Orbion Pharms	LEVOFLOXACIN	levofloxacin	TABLET;ORAL	202200-002	Jan 30, 2012	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Orbion Pharms	CETIRIZINE HYDROCHLORIDE ALLERGY	cetirizine hydrochloride	TABLET;ORAL	078862-001	Feb 19, 2009		OTC	No	No		See Plans and Pricing				See Plans and Pricing
Orbion Pharms	NARATRIPTAN	naratriptan hydrochloride	TABLET;ORAL	091441-002	Apr 30, 2012	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Orbion Pharms

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson

Dow

Harvard Business School

McKinsey

AstraZeneca

Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.